VIRGINIA GUERRERO: Open Payments
NPI 1588423651 · CAMARILLO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$727 in 13 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $587 · 2025 $727
Food & beverage: $727
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $277 |
| Edwards Lifesciences Corporation | 2 | $178 |
| Amgen Inc. | 1 | $115 |
| Novo Nordisk Inc | 2 | $52 |
| Merck Sharp & Dohme LLC | 2 | $52 |
| ABIOMED | 1 | $30 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
Products named: LOKELMA, SAPIEN 3 Ultra RESILIA, Repatha, Wegovy, VERQUVO, FARXIGA, Kerendia.
Industry payments across CA — which companies pay providers there.
